Clinical Trial Update: Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intramyocardial injection of autologous umbilical cord blood mononuclear cells during Fontan surgery for single-ventricle congenital he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Single-ventricle Congenital Heart Disease

Drugs mentioned

• Autologous umbilical cord blood mononuclear cells (autologous umbilical cord blood mononuclear cells)

Snippet

Sponsor: Timothy J Nelson, MD, PhD | Conditions: Congenital Heart Disease, SRV Dependent | Phase 1 | Status: ACTIVE_NOT_RECRUITING